CBD is legal in Canada under specific regulatory conditions. The Cannabis Act (2018) and the Cannabis Regulations govern all aspects of CBD production, distribution, and sale. CBD products are sold only through provincially authorized cannabis retailers. This article summarizes the Canadian regulatory framework for general informational purposes.
The legal framework
CBD is regulated as a cannabis product under the Cannabis Act, regardless of whether the source plant is industrial hemp or higher-THC cannabis. This is different from hemp seed and hemp seed oil, which are regulated as food under the Food and Drugs Act.
Key components of the CBD regulatory framework:
- Producer licensing. All commercial CBD production requires a Health Canada license. Different license classes cover cultivation, processing, and sale.
- Product approval. Each CBD product is registered with Health Canada and must meet specifications.
- Provincial wholesale. Licensed producers sell to provincial wholesale agencies, not directly to consumers.
- Retail authorization. Consumers buy from provincially authorized retailers (government-operated or government-licensed).
- Excise taxation. CBD products carry the federal cannabis excise stamp.
Where to buy CBD legally in Canada
| Province / Territory | Online retailer | Physical retail |
|---|---|---|
| Ontario | Ontario Cannabis Store (OCS) | Authorized cannabis stores |
| Quebec | SQDC | SQDC stores |
| British Columbia | BC Cannabis Stores | BC Cannabis Stores + private retail |
| Alberta | AGLC | Licensed private retail |
| Saskatchewan | Various private | Licensed private retail |
| Manitoba | Various private | Licensed private retail |
| Atlantic provinces | NSLC, NB Cannabis, PEI Cannabis, NLC | Government retailers |
| Territories | Government online + retail | Government retailers |
What is NOT legal CBD sale in Canada
- CBD sold through grocery stores, pharmacies, health food stores, or general online retailers
- CBD products without the federal cannabis excise stamp
- CBD imported from the United States or other countries without Health Canada authorization
- CBD products making therapeutic medical claims
- CBD products sold without standard child-resistant packaging
Products encountered in these contexts are operating outside Canadian regulation. Consumers should not buy them; safety and content are not verified.
Recent regulatory developments
In 2025, Health Canada introduced amendments to the Cannabis Regulations to reduce administrative burden on licensed producers and clarify several aspects of product regulation. The fundamental structure (licensed production, provincial retail, excise stamp) remains intact. Health Canada continues to consult on potential regulatory adjustments; consumers should refer to current Health Canada publications for the most up-to-date information.
The licensed producer system
Canada has hundreds of Health Canada-licensed cannabis producers. License classes include:
- Standard cultivation for commercial cannabis cultivation
- Standard processing for extraction and formulation
- Industrial hemp for hemp grain cultivation
- Research for academic and industry research
- Medical sales for medical cannabis distribution
All commercial CBD production occurs under cultivation and processing licenses, regardless of whether the source plant is industrial hemp or higher-THC cannabis.
Health claims and CBD
CBD products in Canada cannot make therapeutic health claims without Health Canada approval. The only Canadian-authorized CBD-containing prescription drug is Epidiolex/Epidyolex (used for specific seizure disorders). All other CBD products are sold without therapeutic claims; product descriptions focus on cannabinoid content, formulation, and consumer education rather than medical promises.
Therapeutic claims appearing on CBD-related products (sleep aids, anxiety treatments, pain relief) sold outside the authorized cannabis retail channel are regulatory violations. Such products may be either unauthorized CBD or hemp seed oil being marketed deceptively.
Future direction
Health Canada has indicated ongoing interest in potentially expanding CBD's regulatory scope to allow some CBD products to be sold as Natural Health Products or other categories outside the strict Cannabis Act framework. Such changes have not been implemented as of mid-2026; consumers should rely on current regulations rather than anticipated future changes.